Combination of clofarabine, cyclophosphamide, and etoposide for relapsed or refractory childhood and adolescent acute myeloid leukemia

Y Messinger, J Boklan, J Goldberg, SG Dubois, J Oesterheld, O Abla, A Martin, J Weinstein, N Hijiya

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish (US)
JournalPediatric Hematology Oncology
StatePublished - 2017

Cite this

@article{c35d3138b37944b6846da845729cd0d2,
title = "Combination of clofarabine, cyclophosphamide, and etoposide for relapsed or refractory childhood and adolescent acute myeloid leukemia",
author = "Y Messinger and J Boklan and J Goldberg and SG Dubois and J Oesterheld and O Abla and A Martin and J Weinstein and N Hijiya",
year = "2017",
language = "English (US)",
journal = "Pediatric Hematology Oncology",

}

Combination of clofarabine, cyclophosphamide, and etoposide for relapsed or refractory childhood and adolescent acute myeloid leukemia. / Messinger, Y; Boklan, J; Goldberg, J; Dubois, SG; Oesterheld, J; Abla, O; Martin, A; Weinstein, J; Hijiya, N.

In: Pediatric Hematology Oncology, 2017.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Combination of clofarabine, cyclophosphamide, and etoposide for relapsed or refractory childhood and adolescent acute myeloid leukemia

AU - Messinger, Y

AU - Boklan, J

AU - Goldberg, J

AU - Dubois, SG

AU - Oesterheld, J

AU - Abla, O

AU - Martin, A

AU - Weinstein, J

AU - Hijiya, N

PY - 2017

Y1 - 2017

M3 - Article

C2 - 29039989

JO - Pediatric Hematology Oncology

JF - Pediatric Hematology Oncology

ER -